Dayforce Shares Surge Approximately 21%; Check Out 20 Stocks Making Moves in Premarket Trading
Dayforce Inc Acquisition Talks: Shares of Dayforce Inc rose 21.4% in pre-market trading following reports that Thoma Bravo is in discussions to acquire the company.
Notable Gainers: Other stocks experiencing significant gains include Propanc Biopharma (up 253%), Adaptimmune Therapeutics (up 70.3%), and DIH Holding US (up 43.4%).
Significant Losers: TPI Composites saw a drastic decline of 51.1%, while SRx Health Solutions and Empery Digital also faced notable drops of 25.8% and 22.2%, respectively.
Market Overview: The article highlights various stocks' movements in pre-market trading, showcasing both substantial gainers and losers, reflecting market volatility.
Trade with 70% Backtested Accuracy
Analyst Views on EM
About EM
About the author

- EGM Announcement: Smart Share Global has called an extraordinary general meeting on December 31, 2025, to vote on the merger agreement, which is expected to significantly impact the company's operational structure and market positioning.
- Merger Agreement Details: Under the merger agreement dated August 1, 2025, the company will become a wholly-owned subsidiary of MidCo, resulting in the termination of its NASDAQ listing, which could affect its financing capabilities and market visibility.
- Shareholder Voting Rights: Shareholders of record as of December 12, 2025, will be entitled to vote, ensuring shareholder participation in major decisions that may influence the final outcome of the merger.
- Disclosure Requirements: The company emphasizes the need for shareholders to carefully read the materials related to the merger, ensuring transparency and compliance, reflecting its commitment to shareholder interests.
- Extraordinary General Meeting: Smart Share Global has announced an extraordinary general meeting on December 31, 2025, to vote on the merger agreement, which is expected to significantly impact the company's operational model and shareholder structure.
- Merger Agreement Details: Under the merger agreement signed on August 1, 2025, the company will become a wholly-owned subsidiary of MidCo, resulting in the termination of its NASDAQ listing, which may affect its future financing capabilities.
- Shareholder Voting Arrangements: Shareholders of record as of December 12, 2025, will be entitled to vote, ensuring that shareholder opinions on the merger are adequately represented, which could influence the final outcome of the merger.
- Disclosure Requirements: The company urges shareholders to carefully read the materials related to the merger to ensure transparency and compliance, which may impact investor confidence and decision-making.

Dayforce Inc Acquisition Talks: Shares of Dayforce Inc rose 21.4% in pre-market trading following reports that Thoma Bravo is in discussions to acquire the company.
Notable Gainers: Other stocks experiencing significant gains include Propanc Biopharma (up 253%), Adaptimmune Therapeutics (up 70.3%), and DIH Holding US (up 43.4%).
Significant Losers: TPI Composites saw a drastic decline of 51.1%, while SRx Health Solutions and Empery Digital also faced notable drops of 25.8% and 22.2%, respectively.
Market Overview: The article highlights various stocks' movements in pre-market trading, showcasing both substantial gainers and losers, reflecting market volatility.

Merger Announcement: Smart Share Global Limited, known as Energy Monster, has entered into a definitive Merger Agreement with Mobile Charging Group Holdings Limited, which will result in the company being acquired for approximately $327 million and becoming a wholly-owned subsidiary of MidCo.
Shareholder Approval and Premium: The merger offers shareholders a cash consideration of $1.25 per American Depository Share (ADS) and $0.625 per share, representing significant premiums over recent trading prices, and is expected to close in Q4 2025 pending shareholder approval and regulatory conditions.

Analyst Downgrades: Several Wall Street analysts downgraded their ratings for Verve Therapeutics, Inc., with price targets reduced significantly, while Smart Share Global Limited also faced a downgrade but had an increased price target.
Stock Performance: Verve Therapeutics shares closed at $11.38, and Smart Share Global shares closed at $1.12, reflecting the impact of these analyst changes on market perception.
Real-time Intelligence for Traders: Benzinga Pro offers the fastest news alerts and real-time intelligence to help traders succeed in the stock market.
Exclusive Community Access: Joining Benzinga Pro connects you with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.







